ST. JOSEPHS HOSPITAL & MEDICAL CTR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $23.2M
- Transactions
- 3,431
- Companies
- 40
- Average per transaction
- $6,760
Who reported the payments
| Genentech, Inc. | $2,111,772 |
| Tanabe Pharma America, Inc. | $1,958,226 |
| Biogen | $1,780,935 |
| AbbVie | $1,344,724 |
| Intuitive Surgical | $1,263,967 |
| Eli Lilly | $1,080,522 |
| Novartis | $1,005,728 |
| Cochlear Americas | $952,585 |
| Abbott | $764,941 |
| United Therapeutics Corporation | $669,273 |
| Vitalant | $588,963 |
| Globus Medical | $574,772 |
| Ascendis Pharma Endocrinology Inc | $493,231 |
| CSL Behring | $460,312 |
| AstraZeneca | $414,343 |
| Carl Zeiss Meditec, Inc. | $373,494 |
| Stryker | $323,537 |
| Roche Diagnostics Operations, Inc. | $298,946 |
| Roche TCRC, Inc. | $283,573 |
| Boston Scientific | $257,283 |
| Medtronic | $251,995 |
| Edwards Lifesciences | $238,370 |
| Blue Earth Diagnostics | $227,320 |
| Janssen Research & Development, LLC | $223,706 |
| E.r. Squibb & Sons, L.L.C. | $202,238 |
| Nevro Corp. | $197,546 |
| Transmedics, Inc. | $195,790 |
| Seaspine Orthopedics Corporation | $190,283 |
| Takeda Pharmaceuticals U.S.A., Inc. | $172,892 |
| Mitsubishi Tanabe Pharma Development America, Inc. | $161,319 |
| Davol Inc. | $152,533 |
| Mitsubishi Tanabe Pharma Holdings America, Inc. | $145,231 |
| Alphatec Spine, Inc | $138,500 |
| Lundbeck LLC | $136,741 |
| Philips North America LLC | $134,480 |
| Intercept Pharmaceuticals, Inc. | $127,446 |
| Amneal Pharmaceuticals LLC | $126,937 |
| Novocure Inc. | $123,295 |
| Baxter Healthcare | $109,824 |
| Sanofi | $108,927 |